Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATP1A1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | PCDH18 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | CRYL1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | SEC24A | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | PLOD2 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
mRNA | KLF16 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | GNA15 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | FBN1 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | PSD4 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
mRNA | ZFPM1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |